Read + Share
Amedeo Smart
Independent Medical Education
Qian J, Xie Y, Mao Q, Xie Q, et al. A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally-suppressed, HBeAg negative chronic hepatitis B patients. Hepatology 2024 Jul 8. doi: 10.1097/HEP.0000000000001006.PMID: 38976867
Email
LinkedIn
Privacy Policy